LENSAR, Inc.

LNSR Healthcare Medical Devices

LENSAR, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $58.4 million, up 9.24% from fiscal 2024. In the quarter to June 2026, revenue grew 18.4%, EPS grew 291.7% and free cash flow grew 96.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

5.80 0.23 −3.81%
Market cap
$74.1M
P/E
2.0×
Fwd P/E
7.1×
Dividend yield
—
F-score
3/9
Altman Z
−2.84
Beneish M
−4.30
Dividend safety
n/a
Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
— — — 5 4 4 5 3 3
P/E ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
— 2.53 2.53 1.27 1.63 0.78 1.05 1.92 2.38
Altman Z-Score
— — — 0.98 1.47 (1.22) (0.99) (1.26) (2.84)
P/FCF ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
— (4.33) (4.79) 6.10 2.74 (2.32) (2.17) (5.37) (10.13)
P/Operating CF
— (1,221.55) (1,221.55) (16.78) (75.98) (5.83) (92.34) 28.16 225.03
Beneish M-Score
— — (2.95) (3.34) (2.17) (2.80) (2.94) (4.13) (4.30)
P/B ratio
— 0.97 0.97 0.50 1.02 0.66 1.33 21.18 0.00
EV/Sales
— 1.16 1.16 (0.03) 0.89 0.55 0.63 1.62 2.18
EV/EBITDA
— 0.00 0.00 0.05 0.00 0.00 0.00 0.00 0.00
EV/FCF
— (1.63) (1.63) 0.06 (3.31) (1.29) (2.69) (35.72) (8.54)
Current Ratio
— 1.53 2.19 6.90 5.14 2.95 3.99 2.80 1.15
Net Debt/EBITDA
— (0.63) (1.76) 2.55 1.87 0.88 2.76 3.22 0.89
Debt/Equity
— (0.31) (0.66) 0.00 0.00 0.00 0.00 0.00 0.00
ROE
— 55.06% 57.46% (107.89%) (32.11%) (41.12%) (38.14%) (164.03%) 324.05%
ROA
— (97.24%) (46.22%) (34.80%) (26.93%) (32.56%) (22.93%) (46.22%) (49.78%)
ROIC
— 0.00% 0.00% (43.45%) (52.85%) (46.18%) (81.61%) 0.00% 0.00%
Return on Tangible Assets
— (293.44%) (145.49%) (38.96%) (53.18%) (87.12%) (40.53%) (113.62%) (511.49%)
Average Days of Receivables
— 49.42 40.46 27.84 49.13 62.35 34.64 41.52 39.83
Earnings Yield
— (94.64%) (94.64%) (125.07%) (34.89%) (72.16%) (32.89%) (30.43%) (24.94%)
Free Cash Flow Yield
— (28.07%) (28.07%) (42.14%) (16.60%) (53.98%) (22.32%) (2.36%) (10.72%)
Free Cash Flow per Share
— (4.80) (13.72) (3.05) (0.99) (1.47) (0.90) (0.21) (1.25)
Book value per Share
— (19.13) (28.55) 14.54 5.85 4.13 3.05 0.42 (2.18)
Free Cash Flow
— (5.13) (14.68) (14.12) (9.32) (14.97) (9.89) (2.43) (14.91)
EV/EBIT
— 0.00 0.00 0.04 0.00 0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates